Oncolytics Biotech shares are trading higher after JonesTrading initiated covered on the stock with a Buy rating and announced a $9 price target.
Portfolio Pulse from Benzinga Newsdesk
Oncolytics Biotech shares are trading higher after JonesTrading initiated coverage on the stock with a Buy rating and announced a $9 price target.
May 24, 2023 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oncolytics Biotech's stock price is trading higher after JonesTrading initiated coverage with a Buy rating and a $9 price target.
The Buy rating and $9 price target from JonesTrading is a positive signal for Oncolytics Biotech, indicating that the analyst believes the stock has potential for growth. This news is likely to attract more investors and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100